NEOGENOMICS INC — Director's Dealing 2022

Mar 4, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2022-03-01

Reporting Person: Gilbert Halley E (Chief Legal Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-03-01	Common Stock	A	42036	—	Acquired	147396	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-03-01	Stock Option (Right to Buy)	$21.41	A	102623	Acquired	2029-03-01	Common Stock (102623.0)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$42.21	2028-08-17	Common Stock (63331.0)	63331	Direct

Footnotes

F1: On March 1, 2022, Ms. Gilbert was granted 42,036 restricted stock awards. These awards vest ratably over the first four anniversary dates of the grant date.

F2: This balance includes 97 shares that were acquired at a price of $19.16 per share pursuant to NeoGenomics's Employee Stock Purchase Plan (ESPP) during the month ended January 31, 2022. The shares were acquired in transactions exempt from Section 16b-3.

F3: On August 17, 2021, Ms. Gilbert was granted 63,331 stock options. These options vest ratably over the first four anniversary dates of the grant date.

F4: On March 1, 2022, Ms. Gilbert was granted 102,623 stock options. These options vest ratably over the first four anniversary dates of the grant date.